Consultant cardiologist Chris Ellis discusses the recent funding of rosuvastatin, focusing on its use for secondary prevention of cardiovascular disease
Dementia is an incredibly destructive disease that puts a considerable strain on those who develop it, their friends and whānau, and the healthcare system. Here, Professor Ngaire Kerse reviews the 12 modifiable risk factors identified for dementia
Diet is entwined in several of the modifiable risk factors for dementia. In this article, dietitian Leigh O’Brien discusses the role of diet in preventing and managing cognitive decline
Biological medicines have markedly changed the prognoses for many chronic and disabling inflammatory and immunological conditions and cancers. Their use in New Zealand is increasing and, as patents expire on reference or originator “biologics”, the opportunity arises for competitor manufacturers to list biosimilars – highly similar versions of approved biological medicines
Christchurch pharmacist Sarah Mooney discusses the causes of asthma and the effects it can have on children, before delving into treatments and how you can help improve adherence to these
Healthcare Handbook technical editor Carmen Fookesdiscusses the bugs that can bite you in New Zealand, how to tell the difference between itchy red bites, and how to treat them
Jordan Macdonald, a community pharmacist in Dunedin and executive member of NgāKaitiaki o te PunaRongoā (MPA), reflects on the demands of COVID-19, with help from other members of the organisation
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes